1-arylsulfonyl-5-(N-hydroxyacrylamide)tetrahydroquinolines as potent histone deacetylase inhibitors suppressing the growth of prostate cancer cells

Yi-Min Liu, Hsueh Yun Lee, Chun-Han Chen, Chia-Hua Lee, Li-Ting Wang, Shiow Lin Pan, Mei-Jung Lai, Teng-Kuang Yeh, Jing Ping Liou

研究成果: 雜誌貢獻文章

16 引文 斯高帕斯(Scopus)

摘要

This study describes the development of a series of 1-arylsulfonyl-6-(N-hydroxyacrylamide)tetrahydroquinolines, potent histone deacetylase (HDAC) inhibitors which are cytotoxic to PC-3 cells. (E)-N-hydroxy-3-(1-(4-methoxyphenylsulfonyl)-1,2,3,4-tetrahydroquinolin-6-yl)acrylamide (11) exhibits marked anti-HDAC and antiproliferative activity, and is slightly more effective than N1-hydroxy-N8-phenyloctanediamide (SAHA, Vorinostat, 1). In a xenograft tumor model, 11, at doses of 100 or 200 mg/kg orally, suppresses the growth of PC-3 cells and leads to tumor growth inhibition of 38.8% and 57.9%, respectively. Compound 11 is a lead compound for further development of potential prostate cancer inhibitors.
原文英語
頁(從 - 到)320-330
頁數11
期刊European Journal of Medicinal Chemistry
89
DOIs
出版狀態已發佈 - 2015

ASJC Scopus subject areas

  • Drug Discovery
  • Organic Chemistry
  • Pharmacology
  • Medicine(all)

指紋 深入研究「1-arylsulfonyl-5-(N-hydroxyacrylamide)tetrahydroquinolines as potent histone deacetylase inhibitors suppressing the growth of prostate cancer cells」主題。共同形成了獨特的指紋。

  • 引用此